The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
Open accessAbstract
The ubiquitin-proteasome system has numerous crucial roles in physiology and pathophysiology. Fundamental to the specificity of this system are ubiquitin-protein ligases (E3s). Of these, the majority are RING finger and RING finger-related E3s. Many RING finger E3s have roles in processes that are central to the maintenance of genomic integrity and cellular homeostasis, such as the anaphase promoting complex/cyclosome (APC/C), the SKP1–cullin 1–F-box protein (SCF) E3s, MDM2, BRCA1, Fanconi anaemia proteins, CBL proteins, von Hippel–Lindau tumour suppressor (VHL) and SIAH proteins. As a result, many RING finger E3s are implicated in either the suppression or the progression of cancer. This Review summarizes current knowledge in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“Under normoxic conditions, HIFα proteins are hydroxylated on a specific proline residue, creating a binding site for the hydroxyproline-binding pocket of the VHL protein, which leads to CRL2 VHL -mediated ubiquitylation and proteasomal degradatio”
BackgroundIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Audeh, M. W., Carmichael, J., Penson, R. T., Friedlander, M., Powell, B., Bell-McGuinn, K. M., Scott, C., Weitzel, J. N., Oaknin, A., Loman, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60893-8 · Cited by 2,279
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Tutt, A., Robson, M., Garber, J. E., Domchek, S. M., Audeh, M. W., Weitzel, J. N., Friedlander, M., Arun, B., Loman, N., Schmutzler, R. K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60892-6 · Cited by 1,655
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · cited 1×
“The tumour suppressor ARF, which is the product of the CDKN2A locus, binds to the central acidic domain of MDM2 and inhibits its activity towards p53 (Ref”
BackgroundAssociation of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1881 · Cited by 1,433
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“The relationship between MDM2 and p53 was established by early embryonic lethality in Mdm2 −/− mice and their rescue by crossing with Trp53 −/− mic”
BackgroundThe anaphase promoting complex/cyclosome: a machine designed to destroy
Peters, J.-M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1988 · Cited by 1,315
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 1×
“The relationship between MDM2 and p53 was established by early embryonic lethality in Mdm2 −/− mice and their rescue by crossing with Trp53 −/− mic”
BackgroundBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Welcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084 · cited 1×
“Consistent with this, FBW7 is a TSG and loss of FBW7 function is seen in a number of carcinoma”
BackgroundMdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Self-citationMutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Compagno, M., Lim, W. K., Grunn, A., Nandula, S. V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., et al. (2009) · Nature · doi:10.1038/nature07968 · Cited by 1,038
The Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase
Joazeiro, C. A. P., Wing, S. S., Huang, H.-K., Leverson, J. D., Hunter, T., & Liu, Y.-C. (1999) · Science · doi:10.1126/science.286.5438.309 · Cited by 1,034
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80231-2 · Cited by 1,001
Self-citationYang, Y., Fang, S., Jensen, J. P., Weissman, A. M., & Ashwell, J. D. (2000) · Science · doi:10.1126/science.288.5467.874 · Cited by 988
Self-citationPromiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 981
Self-citationIsaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
Frescas, D., & Pagano, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2396 · Cited by 890
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
Levkowitz, G., Waterman, H., Zamir, E., Kam, Z., Oved, S., Langdon, W. Y., Beguinot, L., Geiger, B., & Yarden, Y. (1998) · Genes & Development · doi:10.1101/gad.12.23.3663 · Cited by 865
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex
Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E. M., Behrens, J., Sommer, T., & Birchmeier, W. (2002) · Nature Cell Biology · doi:10.1038/ncb758 · Cited by 846
Structure of a c-Cbl–UbcH7 Complex
Zheng, N., Wang, P., Jeffrey, P. D., & Pavletich, N. P. (2000) · Cell · doi:10.1016/s0092-8674(00)00057-x · Cited by 839
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
Kamura, T., Koepp, D. M., Conrad, M. N., Skowyra, D., Moreland, R. J., Iliopoulos, O., Lane, W. S., Kaelin, W. G., Elledge, S. J., Conaway, R. C., et al. (1999) · Science · doi:10.1126/science.284.5414.657 · Cited by 781
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751
Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors
Issaeva, N., Bozko, P., Enge, M., Protopopova, M., Verhoef, L. G. G. C., Masucci, M., Pramanik, A., & Selivanova, G. (2004) · Nature Medicine · doi:10.1038/nm1146 · Cited by 750
The genetic basis of kidney cancer: a metabolic disease
Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.47 · Cited by 744
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Tumour suppression by the human von Hippel-Lindau gene product
Iliopoulos, O., Kibel, A., Gray, S., & Kaelin, W. G. (1995) · Nature Medicine · doi:10.1038/nm0895-822 · Cited by 703
Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
Kibel, A., Iliopoulos, O., DeCaprio, J. A., & Kaelin, W. G. (1995) · Science · doi:10.1126/science.7660130 · Cited by 671
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
Bachmaier, K., Krawczyk, C., Kozieradzki, I., Kong, Y.-Y., Sasaki, T., Oliveira-dos-Santos, A., Mariathasan, S., Bouchard, D., Wakeham, A., Itie, A., et al. (2000) · Nature · doi:10.1038/35003228 · Cited by 666
Self-citationO'Neil, J., Grim, J., Strack, P., Rao, S., Tibbitts, D., Winter, C., Hardwick, J., Welcker, M., Meijerink, J. P., Pieters, R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070876 · Cited by 663
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Welcsh, P. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.705 · Cited by 648 · cited 1×
“BRCA1 is a tumour suppressor that is frequently mutated in familial breast and ovarian cance”
BackgroundHashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., & Ohta, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000881200 · Cited by 634
Cbl-b regulates the CD28 dependence of T-cell activation
Chiang, Y. J., Kole, H. K., Brown, K., Naramura, M., Fukuhara, S., Hu, R.-J., Jang, I. K., Gutkind, J. S., Shevach, E., & Gu, H. (2000) · Nature · doi:10.1038/35003235 · Cited by 621
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611
Signaling to p53: ribosomal proteins find their way
Zhang, Y., & Lu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.024 · Cited by 591
How the Fanconi Anemia Pathway Guards the Genome
Moldovan, G.-L., & D'Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 590
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
Brzović, P. S., Rajagopal, P., Hoyt, D. W., King, M., & Klevit, R. E. (2001) · Nature Structural Biology · doi:10.1038/nsb1001-833 · Cited by 573
Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide
Bernal, F., Tyler, A. F., Korsmeyer, S. J., Walensky, L. D., & Verdine, G. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0693587 · Cited by 556
Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5
Dai, M.-S., & Lu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403722200 · Cited by 534
Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., & Linehan, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10589 · Cited by 531
The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
Knipscheer, P., Räschle, M., Smogorzewska, A., Enoiu, M., Ho, T. V., Schärer, O. D., Elledge, S. J., & Walter, J. C. (2009) · Science · doi:10.1126/science.1182372 · Cited by 518
Iwai, K., Yamanaka, K., Kamura, T., Minato, N., Conaway, R. C., Conaway, J. W., Klausner, R. D., & Pause, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12436 · Cited by 508
Skp2 is oncogenic and overexpressed in human cancers
Gstaiger, M., Jordan, R., Lim, M., Catzavelos, C., Mestan, J., Slingerland, J., & Krek, W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081474898 · Cited by 505
Huang, F., Kirkpatrick, D., Jiang, X., Gygi, S., & Sorkin, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.018 · Cited by 497
Pause, A., Lee, S., Worrell, R. A., Chen, D. Y. T., Burgess, W. H., Linehan, W. M., & Klausner, R. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2156 · Cited by 493
BRCA1 and its toolbox for the maintenance of genome integrity
Huen, M. S. Y., Sy, S. M. H., & Chen, J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2831 · Cited by 490
Staudt, L. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000109 · Cited by 485
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450
Eisen, A., Lubinski, J., Klijn, J., Moller, P., Lynch, H. T., Offit, K., Weber, B., Rebbeck, T., Neuhausen, S. L., Ghadirian, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7138 · Cited by 443
Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu
Xu, W., Marcu, M., Yuan, X., Mimnaugh, E., Patterson, C., & Neckers, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202365899 · Cited by 433
Maranchie, J. K., Vasselli, J. R., Riss, J., Bonifacino, J. S., Linehan, W. M., & Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00044-2 · Cited by 432
Mutation of the RAD51C gene in a Fanconi anemia–like disorder
Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.570 · Cited by 408 · cited 1×
“Beyond the 13 FANC genes, biallelic mutations in either of two other genes have recently been identified as being associated with Fanconi anaemi”
BackgroundNakayama, K., Frew, I. J., Hagensen, M., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument-Bromage, H., Tempst, P., Frappell, P. B., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.001 · Cited by 405
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
Sanada, M., Suzuki, T., Shih, L.-Y., Otsu, M., Kato, M., Yamazaki, S., Tamura, A., Honda, H., Sakata-Yanagimoto, M., Kumano, K., et al. (2009) · Nature · doi:10.1038/nature08240 · Cited by 402
The Cbl interactome and its functions
Schmidt, M. H. H., & Dikic, I. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1762 · Cited by 395
Emi1 Is a Mitotic Regulator that Interacts with Cdc20 and Inhibits the Anaphase Promoting Complex
Reimann, J. D. R., Freed, E., Hsu, J. Y., Kramer, E. R., Peters, J.-M., & Jackson, P. K. (2001) · Cell · doi:10.1016/s0092-8674(01)00361-0 · Cited by 389
Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M., & Krek, W. (1999) · Genes & Development · doi:10.1101/gad.13.14.1822 · Cited by 379
Grand, F. H., Hidalgo-Curtis, C. E., Ernst, T., Zoi, K., Zoi, C., McGuire, C., Kreil, S., Jones, A., Score, J., Metzgeroth, G., et al. (2009) · Blood · doi:10.1182/blood-2008-12-194548 · Cited by 378
Honda, R., & Yasuda, H. (2000) · Oncogene · doi:10.1038/sj.onc.1203464 · Cited by 376
The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress
Morris, J. R., Boutell, C., Keppler, M., Densham, R., Weekes, D., Alamshah, A., Butler, L., Galanty, Y., Pangon, L., Kiuchi, T., et al. (2009) · Nature · doi:10.1038/nature08593 · Cited by 375
Deregulated degradation of the cdk inhibitor p27 and malignant transformation
Bloom, J., & Pagano, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00098-6 · Cited by 374
Genomic stability and tumour suppression by the APC/C cofactor Cdh1
García-Higuera, I., Manchado, E., Dubus, P., Cañamero, M., Méndez, J., Moreno, S., & Malumbres, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1742 · Cited by 363
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361
Ruffner, H., Joazeiro, C. A. P., Hemmati, D., Hunter, T., & Verma, I. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081068398 · Cited by 359
Nikolaev, A. Y., Li, M., Puskas, N., Qin, J., & Gu, W. (2003) · Cell · doi:10.1016/s0092-8674(02)01255-2 · Cited by 356
Huang, H.-K., Joazeiro, C. A. P., Bonfoco, E., Kamada, S., Leverson, J. D., & Hunter, T. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61427-4 · Cited by 356
Mdm2-mediated ubiquitylation: p53 and beyond
Marine, J.-C., & Lozano, G. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.68 · Cited by 354
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
Jeon, M.-S., Atfield, A., Venuprasad, K., Krawczyk, C., Sarao, R., Elly, C., Yang, C., Arya, S., Bachmaier, K., Su, L., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.013 · Cited by 348
Smogorzewska, A., Desetty, R., Saito, T. T., Schlabach, M., Lach, F. P., Sowa, M. E., Clark, A. B., Kunkel, T. A., Harper, J. W., Colaiácovo, M. P., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.023 · Cited by 334
Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist
Poole, A. J., Li, Y., Kim, Y., Lin, S.-C. J., Lee, W.-H., & Lee, E. Y.-H. P. (2006) · Science · doi:10.1126/science.1130471 · Cited by 332
E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1
Hsu, J. Y., Reimann, J. D. R., Sørensen, C. S., Lukas, J., & Jackson, P. K. (2002) · Nature Cell Biology · doi:10.1038/ncb785 · Cited by 331
MDM2 interacts with MDMX through their RING finger domains
Tanimura, S., Ohtsuka, S., Mitsui, K., Shirouzu, K., Yoshimura, A., & Ohtsubo, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00254-9 · Cited by 324
Yokouchi, M., Kondo, T., Houghton, A., Bartkiewicz, M., Horne, W. C., Zhang, H., Yoshimura, A., & Baron, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31707 · Cited by 323
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells
Yang, Y., Ludwig, R. L., Jensen, J. P., Pierre, S. A., Medaglia, M. V., Davydov, I. V., Safiran, Y. J., Oberoi, P., Kenten, J. H., Phillips, A. C., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.029 · Cited by 322
Self-citationMacKay, C., Déclais, A.-C., Lundin, C., Agostinho, A., Deans, A. J., MacArtney, T. J., Hofmann, K., Gartner, A., West, S. C., Helleday, T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.021 · Cited by 313
SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation
Westbrook, T. F., Hu, G., Ang, X. L., Mulligan, P., Pavlova, N. N., Liang, A., Leng, Y., Maehr, R., Shi, Y., Harper, J. W., et al. (2008) · Nature · doi:10.1038/nature06780 · Cited by 311
Danovi, D., Meulmeester, E., Pasini, D., Migliorini, D., Capra, M., Frenk, R., de Graaf, P., Francoz, S., Gasparini, P., Gobbi, A., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5835-5843.2004 · Cited by 310
v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas.
Langdon, W. Y., Hartley, J. W., Klinken, S. P., Ruscetti, S. K., & Morse, H. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1168 · Cited by 307
Proteasome inhibitors in cancer therapy
Crawford, L. J., Walker, B., & Irvine, A. E. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0121-7 · Cited by 299
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype
Stoepker, C., Hain, K., Schuster, B., Hilhorst-Hofstee, Y., Rooimans, M. A., Steltenpool, J., Oostra, A. B., Eirich, K., Korthof, E. T., Nieuwint, A. W. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.751 · Cited by 299
Riemenschneider, M. J., Büschges, R., Wolter, M., REIFENBERGER, J., Boström, J. P., Kraus, J. A., Schlegel, U. S., & Reifenberger, G. (1999) · PubMed · Cited by 297
UBE2T Is the E2 in the Fanconi Anemia Pathway and Undergoes Negative Autoregulation
Machida, Y. J., Machida, Y., Chen, Y., Gurtan, A. M., Kupfer, G. M., D'Andrea, A. D., & Dutta, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.024 · Cited by 291
The multiple levels of regulation by p53 ubiquitination
Lee, J. T., & Gu, W. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.77 · Cited by 289
Linke, K., Mace, P. D., Smith, C. A., Vaux, D. L., Silke, J., & Day, C. L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402309 · Cited by 288
Endocytosis of Receptor Tyrosine Kinases Is Driven by Monoubiquitylation, Not Polyubiquitylation
Mosesson, Y., Shtiegman, K., Katz, M., Zwang, Y., Vereb, G., Szollosi, J., & Yarden, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300096200 · Cited by 286
BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP
Yu, X., Fu, S., Lai, M., Baer, R., & Chen, J. (2006) · Genes & Development · doi:10.1101/gad.1431006 · Cited by 284
Role of the F-box protein Skp2 in lymphomagenesis
Latres, E., Chiarle, R., Schulman, B. A., Pavletich, N. P., Pellicer, A., Inghirami, G., & Pagano, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041475098 · Cited by 279
Kratz, K., Schöpf, B., Kaden, S., Sendoel, A., Eberhard, R., Lademann, C., Cannavó, E., Sartori, A. A., Hengartner, M. O., & Jiricny, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.022 · Cited by 272
Role of direct interaction in BRCA1 inhibition of estrogen receptor activity
Fan, S., Ma, Y. X., Wang, C., Yuan, R.-Q., Meng, Q., Wang, J.-A., Erdos, M., Goldberg, I. D., Webb, P., Kushner, P. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204073 · Cited by 263
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo
Ringshausen, I., O'Shea, C. C., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.010 · Cited by 256
Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors
Zimmer, M., Doucette, D., Siddiqui, N., & Iliopoulos, O. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.89.2.2 · Cited by 244
Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms
Stad, R., Little, N. A., Xirodimas, D. P., Frenk, R., van der Eb, A. J., Lane, D. P., Saville, M. K., & Jochemsen, A. G. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve227 · Cited by 234
Escape from Cbl-mediated downregulation
Peschard, P., & Park, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00136-3 · Cited by 233
Flt3-dependent transformation by inactivating c-Cbl mutations in AML
Sargin, B., Choudhary, C., Crosetto, N., Schmidt, M. H. H., Grundler, R., Rensinghoff, M., Thiessen, C., Tickenbrock, L., Schwäble, J., Brandts, C., et al. (2007) · Blood · doi:10.1182/blood-2007-01-066076 · Cited by 213
Tumor suppression and normal aging in mice with constitutively high p53 activity
Mendrysa, S. M., O'Leary, K. A., McElwee, M. K., Michalowski, J., Eisenman, R. N., Powell, D. A., & Perry, M. E. (2006) · Genes & Development · doi:10.1101/gad.1378506 · Cited by 210 · cited 1×
“The sensitive nature of the p53–MDM2 relationship is underscored by the decrease in tumour formation in mice with reduced MDM2 and dramatic apoptosis in multiple tissues seen with an inducible p53 in mice lacking Mdm2 (Ref”
BackgroundPoyurovsky, M. V., Priest, C., Kentsis, A., Borden, K. L., Pan, Z., Pavletich, N., & Prives, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601465 · Cited by 203
Gilliland, D. G., & Griffin, J. D. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00003 · Cited by 202
ErbB2 Degradation Mediated by the Co-chaperone Protein CHIP
Zhou, P., Fernandes, N., Dodge, I. L., Reddi, A. L., Rao, N., Safran, H., DiPetrillo, T. A., Wazer, D. E., Band, V., & Band, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209640200 · Cited by 200
Ubiquitin in trafficking: The network at work
Acconcia, F., Sigismund, S., & Polo, S. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.014 · Cited by 198
Snouwaert, J. N., Gowen, L. C., Latour, A. M., Mohn, A. R., Xiao, A., DiBiase, L., & Koller, B. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203334 · Cited by 197
Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein
Xia, Y., Pao, G. M., Chen, H.-W., Verma, I. M., & Hunter, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204591200 · Cited by 196
Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase
Eakin, C. M., MacCoss, M. J., Finney, G. L., & Klevit, R. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610887104 · Cited by 192
Identification of a cryptic nucleolar-localization signal in MDM2
Lohrum, M. A. E., Ashcroft, M., Kubbutat, M. H. G., & Vousden, K. H. (2000) · Nature Cell Biology · doi:10.1038/35004057 · Cited by 189
Control of chromosome stability by the β-TrCP–REST–Mad2 axis
Guardavaccaro, D., Frescas, D., Dorrello, N. V., Peschiaroli, A., Multani, A. S., Cardozo, T., Lasorella, A., Iavarone, A., Chang, S., Hernando, E., et al. (2008) · Nature · doi:10.1038/nature06641 · Cited by 188
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation
Tsai, Y. C., Mendoza, A., Mariano, J. M., Zhou, M., Kostova, Z., Chen, B., Veenstra, T., Hewitt, S. M., Helman, L. J., Khanna, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1686 · Cited by 186
Self-citationControl of cell growth by the SCF and APC/C ubiquitin ligases
Skaar, J. R., & Pagano, M. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.08.004 · Cited by 181
Qiu, X., & Goldberg, A. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232580999 · Cited by 176
Miyake, S., Mullane-Robinson, K. P., Lill, N. L., Douillard, P., & Band, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16619 · Cited by 175
COP1 is a tumour suppressor that causes degradation of ETS transcription factors
Vitari, A. C., Leong, K. G., Newton, K., Yee, C., O’Rourke, K., Liu, J., Phu, L., Vij, R., Ferrando, R., Couto, S. S., et al. (2011) · Nature · doi:10.1038/nature10005 · Cited by 170
An essential function of the extreme C-terminus of MDM2 can be provided by MDMX
Uldrijan, S., Pannekoek, W., & Vousden, K. H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601469 · Cited by 170
Kassenbrock, C. K., & Anderson, S. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404114200 · Cited by 168
Eletr, Z. M., Huang, D. T., Duda, D. M., Schulman, B. A., & Kuhlman, B. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb984 · Cited by 167
CUL7: A DOC domain-containing cullin selectively binds Skp1⋅Fbx29 to form an SCF-like complex
Dias, D. C., Dolios, G., Wang, R., & Pan, Z.-Q. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252646399 · Cited by 165
Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway
Horn, H. F., & Vousden, K. H. (2008) · Oncogene · doi:10.1038/onc.2008.189 · Cited by 162
Joukov, V., Chen, J., Fox, E. A., Green, J. B. A., & Livingston, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211427098 · Cited by 161
Spontaneous tumor rejection by cbl-b –deficient CD8+ T cells
Loeser, S., Loser, K., Bijker, M. S., Rangachari, M., van der Burg, S. H., Wada, T., Beissert, S., Melief, C. J. M., & Penninger, J. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061699 · Cited by 161
WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1–CUL4–ROC1 ligase
Hu, J., Zacharek, S., He, Y. J., Lee, H., Shumway, S., Duronio, R. J., & Xiong, Y. (2008) · Genes & Development · doi:10.1101/gad.1624008 · Cited by 161
BRCA1 Regulates Acetylation and Ubiquitination of Estrogen Receptor-α
Ma, Y., Fan, S., Hu, C., Meng, Q., Fuqua, S. A. W., Pestell, R. G., Tomita, Y. A., & Rosen, E. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0218 · Cited by 157
Wäsch, R., & Engelbert, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208017 · Cited by 152
The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched- related gene, TRC8
Gemmill, R. M., West, J. D., Boldog, F. L., Tanaka, N., Robinson, L. J., Smith, D. I., Li, F., & Drabkin, H. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9572 · Cited by 152
Mapping the Functional Domains of BRCA1
Meza, J. E., Brzović, P. S., King, M., & Klevit, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5659 · Cited by 142
Dominguez, C., Bonvin, A. M. J. J., Winkler, G. S., van Schaik, F. M. A., Timmers, H. T. M., & Boelens, R. (2004) · Structure · doi:10.1016/j.str.2004.03.004 · Cited by 137
Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice
Migliorini, D., Bogaerts, S., Defever, D., Vyas, R., Denecker, G., Radaelli, E., Zwolińska, A., Depaepe, V., Hochepied, T., Skarnes, W. C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45784 · Cited by 136
Reindl, C., Quentmeier, H., Petropoulos, K., Greif, P. A., Benthaus, T., Argiropoulos, B., Mellert, G., Vempati, S., Duyster, J., Buske, C., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1325 · Cited by 136
Ma, Y., Katiyar, P., Jones, L. P., Fan, S., Zhang, Y., Furth, P. A., & Rosen, E. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0488 · Cited by 131
Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of Age
Kales, S. C., Ryan, P. E., Nau, M. M., & Lipkowitz, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0610 · Cited by 130
Self-citationAblation of Cbl-b provides protection against transplanted and spontaneous tumors
Chiang, J. Y., Jang, I. K., Hodes, R., & Gu, H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29472 · Cited by 124
Lai, Z., Yang, T., Kim, Y. B., Sielecki, T. M., Diamond, M. A., Strack, P. R., Rolfe, M., Caligiuri, M., Benfield, P. A., Auger, K. R., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212428599 · Cited by 115
Bonita, D. P., Miyake, S., Lupher, M., Langdon, W. Y., & Band, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4597 · Cited by 114
Tan, Y. C., Krishnaswamy, S., Nandi, S., Kanteti, R., Vora, S., Onel, K., Hasina, R., Lo, F.-Y., El‐Hashani, E., Cervantes, G. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008972 · Cited by 112
Self-citationMyeloid Leukemia Development in c-Cbl RING Finger Mutant Mice Is Dependent on FLT3 Signaling
Rathinam, C., Thien, C. B. F., Flavell, R. A., & Langdon, W. Y. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.008 · Cited by 109
Alterations of anaphase-promoting complex genes in human colon cancer cells
Wang, Q., Moyret‐Lalle, C., Couzon, F., Surbiguet-Clippe, C., Saurin, J., Lorca, T., Navarro, C., & Puisieux, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206224 · Cited by 107
Essential Role of E3 Ubiquitin Ligase Activity in Cbl-b–Regulated T Cell Functions
Paolino, M., Thien, C. B. F., Gruber, T., Hinterleitner, R., Baier, G., Langdon, W. Y., & Penninger, J. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003390 · Cited by 106
Regulating the regulator: negative regulation of Cbl ubiquitin ligases
Ryan, P. E., Davies, G., Nau, M. M., & Lipkowitz, S. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.004 · Cited by 102
Self-citationExpression of Pirh2, a Newly Identified Ubiquitin Protein Ligase, in Lung Cancer
Duan, W., Gao, L., Druhan, L. J., Zhu, W., Morrison, C., Otterson, G. A., & Villalona-Calero, M. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh292 · Cited by 99
Cancer predisposing BARD1 mutations in breast–ovarian cancer families
Ratajska, M., Antoszewska, E., Piskorz, A., Brożek, I., Borg, Å., Kusmierek, H., Biernat, W., & Limon, J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1403-8 · Cited by 96
Li, Y., Kumar, S., Tang, W., Spiegelman, V. S., & Fuchs, S. Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.4038-4048.2004 · Cited by 91
Brakeleer, S. D., Grève, J. D., Loris, R., Janin, N., Lissens, W., Sermijn, E., & Teugels, E. (2010) · Human Mutation · doi:10.1002/humu.21200 · Cited by 89
Zhao, C. Y., Székely, L., Bao, W., & Selivanova, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2787 · Cited by 81
Siah Proteins: Novel Drug Targets in the Ras and Hypoxia Pathways
House, C. M., Möller, A., & Bowtell, D. D. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1676 · Cited by 80
Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis
Kee, Y., Kim, J. M., & D’Andrea, A. D. (2009) · Genes & Development · doi:10.1101/gad.1761309 · Cited by 79
PARC and CUL7 Form Atypical Cullin RING Ligase Complexes
Skaar, J. R., Florens, L. A., Tsutsumi, T., Arai, T., Tron, A. E., Swanson, S. K., Washburn, M. P., & DeCaprio, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3241 · Cited by 78
Wiggins, C. M., Tsvetkov, P., Johnson, M. A., Joyce, C. L., Lamb, C. A., Bryant, N. J., Komander, D., Shaul, Y., & Cook, S. J. (2011) · Journal of Cell Science · doi:10.1242/jcs.058438 · Cited by 77
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
Okamoto, K., Taya, Y., & Nakagama, H. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.021 · Cited by 76
Lee, J. P., Brauweiler, A., Rudolph, M., Hooper, J. E., Drabkin, H. A., & Gemmill, R. M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0491 · Cited by 76
Patterson, D. M., Gao, D., Trahan, D. N., Johnson, B. A., Ludwig, A. D., Barbieri, E., Chen, Z., Diaz-Miron, J. L., Vassilev, L. T., Shohet, J. M., et al. (2011) · Angiogenesis · doi:10.1007/s10456-011-9210-8 · Cited by 70
The Ubiquitin Ligase SCF(βTrCP) Regulates the Degradation of the Growth Hormone Receptor
van Kerkhof, P., Putters, J., & Strous, G. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702610200 · Cited by 68
CUL7 Is a Novel Antiapoptotic Oncogene
Kim, S. S., Shago, M., Kaustov, L., Boutros, P. C., Clendening, J. W., Sheng, Y., Trentin, G. A., Baršytė-Lovejoy, D., Mao, D. Y. L., Kay, R. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0644 · Cited by 68
Jones, L. P., Tilli, M. T., Assefnia, S., Torre, K. M., Halama, E. D., Parrish, A. R., Rosen, E. M., & Furth, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210674 · Cited by 65
Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
Kitagaki, J., Agama, K., Pommier, Y. G., Yang, Y., & Weissman, A. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0063 · Cited by 62
Self-citationEttenberg, S. A., Rubinstein, Y., Banerjee, P., Nau, M. M., Keane, M., & Lipkowitz, S. (1999) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.1999.0157 · Cited by 61
Self-citationA role of estrogen/ERα signaling in BRCA1-associated tissue-specific tumor formation
Li, W., Xiao, C., Vonderhaar, B. K., & Deng, C.-X. (2007) · Oncogene · doi:10.1038/sj.onc.1210527 · Cited by 60
Therapeutic Targets in the ARF Tumor Suppressor Pathway
Saporita, A. J., Maggi, L. B., Apicelli, A. J., & Weber, J. D. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058869 · Cited by 60
Naramura, M., Nandwani, N., Gu, H., Band, V., & Band, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007575107 · Cited by 58
Lehman, N. L., Verschuren, E. W., Hsu, J. Y., Cherry, A. M., & Jackson, P. K. (2006) · Cell Cycle · doi:10.4161/cc.5.14.2925 · Cited by 52
Tovar, C., Higgins, B., Kolinsky, K. D., Xia, M., Packman, K. E., Heimbrook, D. C., & Vassilev, L. T. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-49 · Cited by 41
Ryan, P. E., Sivadasan-Nair, N., Nau, M. M., Nicholas, S., & Lipkowitz, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091157 · Cited by 39
Self-citationThien, C. B. F., Dagger, S. A., Steer, J. H., Köentgen, F., Jansen, E. S., Scott, C. L., & Langdon, W. Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094920 · Cited by 31
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer
Sabatier, R., Adélaïde, J., Finetti, P., Ferrari, A., Huiart, L., Sobol, H., Chaffanet, M., Birnbaum, D., & Bertucci, F. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20822 · Cited by 31
Bo, M. D., Secchiero, P., Degan, M., Marconi, D., Bomben, R., Pozzato, G., Gaïdano, G., Poeta, G. D., Forconi, F., Zauli, G., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08185.x · Cited by 29
Mechanism of BRCA1-Mediated Inhibition of Progesterone Receptor Transcriptional Activity
Katiyar, P., Ma, Y., Riegel, A. T., Fan, S., & Rosen, E. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0347 · Cited by 29
BRCA1 ubiquitylation of CtIP: Just the tIP of the iceberg?
Barber, L. J., & Boulton, S. J. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.08.009 · Cited by 16
Cited by
Ubiquitination in disease pathogenesis and treatment
Popovic, D., Vucic, D., & Dikic, I. (2014) · Nature Medicine · doi:10.1038/nm.3739 · Cited by 1,401
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 831
Zinc in Wound Healing Modulation
Lin, P.-H., Sermersheim, M., Li, H., Lee, P. H. U., Steinberg, S. M., & Ma, J. (2017) · Nutrients · doi:10.3390/nu10010016 · Cited by 643
HECT and RING finger families of E3 ubiquitin ligases at a glance
Metzger, M. B., Hristova, V. A., & Weissman, A. M. (2012) · Journal of Cell Science · doi:10.1242/jcs.091777 · Cited by 630
Self-citationRING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination
Metzger, M. B., Pruneda, J. N., Klevit, R. E., & Weissman, A. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.026 · Cited by 611
Self-citation
Metadata
- Authors
- Lipkowitz, S., & Weissman, A. M.
- Venue
- Nature Reviews Cancer
- Published
- 2011-08-24
- Volume
- 11
- Issue
- 9
- Pages
- 629-643
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2084372424
- Cited by
- 415
- References
- 188
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.